Koç University Report issue

Academic/Hospital Phase 2 Phase 3 Phase 4
Founded: Istanbul Turkey (1993)

Organization Overview

First Clinical Trial
2017
NCT03314727
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2023

Timeline

NOW
  • Now

Alternative names

Koç University | Koc University Hospital

Active Ingredients

Drugs in Phase 4 Trials (4)

chamomile (1 trial)

hyaluronic acid (1 trial)

tea (1 trial)

terpinen-4-ol (1 trial)

Drugs in Phase 3 Trials (2)

favipiravir (1 trial)

ribavirin (virazole) (1 trial)

Drugs in Phase 2 Trials (1)

sorbitol (1 trial)

Drugs in Other Trials (2)

norepinephrine (levophed) (1 trial)

sodium chloride (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Blepharitis (Phase 4)

Fatty Liver (Phase 2)

Liver Diseases (Phase 2)

Non-alcoholic Fatty Liver Disease (Phase 2)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 6
  • # of Trial APIs: 9